Literature DB >> 18343430

Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004.

Jeffrey M Woldrich1, Katherine Mallin, Jamie Ritchey, Peter R Carroll, Christopher J Kane.   

Abstract

PURPOSE: We analyzed patterns of disease presentation and outcome of renal cell carcinomas by gender using data from the National Cancer Database during a 10-year period. We hypothesized that women presented with lower stage disease and had increased survival than men due to increased imaging.
MATERIALS AND METHODS: The National Cancer Database is a nationwide oncology data set that currently captures approximately 75% of all newly diagnosed cancer cases from more than 1,400 facility based cancer registries in the United States annually since 1985. The National Cancer Database was queried for adults with renal cell carcinoma diagnosed between 1993 and 2004. Cases were examined according to gender in relation to mean age, American Joint Committee on Cancer stage, histology, grade, tumor size, mortality and race.
RESULTS: We identified a total of 236,930 patients with renal cell carcinoma diagnosed between 1993 and 2004 from the National Cancer Database. A total of 89,243 (37.7%) were female and 147,687 (62.3%) were male. Mean age was greater in females (64.3) than in males (62.9) (p <0.001). Women had a higher percentage of stage I tumors (54.1% vs 48.5%, p <0.001). Progressive stage migration was documented in men and women. A trend toward increased survival was noted in women relative to men that did not reach statistical significance.
CONCLUSIONS: Results from this study show a ratio of 1.65 of renal cell carcinoma for males compared to females. Women are more likely than men to have stage I tumors. Both men and women have demonstrated stage migration, although women more so than men.

Entities:  

Mesh:

Year:  2008        PMID: 18343430     DOI: 10.1016/j.juro.2008.01.024

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

1.  Asymptomatic microscopic hematuria in women requires separate guidelines.

Authors:  Oz Harmanli; Beril Yuksel
Journal:  Int Urogynecol J       Date:  2012-11-14       Impact factor: 2.894

2.  Trends in renal tumor surgery delivery within the United States.

Authors:  Lori M Dulabon; William T Lowrance; Paul Russo; William C Huang
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

3.  Impact of Charlson's comorbidity index on overall survival following tumor nephrectomy for renal cell carcinoma.

Authors:  M Hammad Ather; Syed M Nazim
Journal:  Int Urol Nephrol       Date:  2009-08-28       Impact factor: 2.370

4.  Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.

Authors:  Matthias May; Atiqullah Aziz; Richard Zigeuner; Thomas Chromecki; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Andrea Tubaro; Ioman Coman; Michael Truss; Orietta Dalpiaz; Bernd Hoschke; Christian Gilfrich; Bogdan Feciche; Anette Stoltze; Fabian Fenske; Hans-Martin Fritsche; Robert S Figenshau; Kerry Madison; Manuel Sánchez-Chapado; Maria Del Carmen Santiago Martin; Luigi Salzano; Giuseppe Lotrecchiano; Steven Joniau; Raphaela Waidelich; Christian Stief; Sabine Brookman-May
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

5.  Does gender influence morbidity or mortality in the surgical treatment of renal masses?

Authors:  Brian J Minnillo; Andrew Horowitz; Antonio Finelli; Shabbir M H Alibhai; Lee E Ponsky; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

6.  Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.

Authors:  Hiten D Patel; Max Kates; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-03-12       Impact factor: 3.498

7.  The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma.

Authors:  Stênio de Cássio Zequi; José Humberto G T Fregnani; Ricardo L Favaretto; Walter H Costa; Rodrigo S Madeira Campos; Francisco P Fonseca; Gustavo C Guimaraes; Fernando A Soares; Isabela W da Cunha; Ademar Lopes
Journal:  World J Urol       Date:  2012-05-06       Impact factor: 4.226

Review 8.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

9.  Evaluation of renal lesions using contrast-enhanced ultrasound (CEUS); a 10-year retrospective European single-centre analysis.

Authors:  Johannes Rübenthaler; G Negrão de Figueiredo; K Mueller-Peltzer; D A Clevert
Journal:  Eur Radiol       Date:  2018-05-09       Impact factor: 5.315

10.  Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India.

Authors:  Manjit K Rana; Tushar S Barwal; Uttam Sharma; Richika Bansal; Karuna Singh; Amrit Pal S Rana; Aklank Jain; Utkarshni Khera
Journal:  Cureus       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.